Subtypes


Web

  • http://www.drugs.com/mtm/golimumab.html
  • Golimumab is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or ulcerative colitis.
  • http://www.netdoctor.co.uk/medicines/aches-and-pains/a8798/simpon...
  • Golimumab is used in combination with methotrexate, when other DMARDs, for example sulfasalazine, methotrexate have not been effective.
  • http://www.medicines.org.uk/emc/medicine/23766
  • Simponi is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are i...
  • http://www.nps.org.au/medicines/muscles-bones-and-joints/antirheu...
  • Simponi SmartJect injector pen Solution for injection is a brand of medicine containing the active ingredient golimumab.
  • http://www.centerwatch.com/drug-information/fda-approved-drugs/dr...
  • The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.
  • http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0071302/
  • Golimumab (Simponi) (Subcutaneous Injection): Adult Patients with Moderately to Severely Active Ulcerative Colitis Who Have Had an Inadequate Response to, or Have Medical Contraindications for, Conventional Therapies [Internet].
  • http://www.allinahealth.org/CCS/doc/Detailed_Drugs/47/602971.htm
  • Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with tumor necrosis factor (TNF) blockers, of which golimumab is a member .
  • http://www.drugbank.ca/drugs/DB06674
  • Golimumab is a human IgG1? monoclonal antibody derived from immunizing genetically engineered mice with human TNF?.
  • http://livertox.nlm.nih.gov/Golimumab.htm
  • Golimumab is a human monoclonal antibody to tumor necrosis factor (TNF) alpha that is used in the treatment of rheumatoid arthritis and ulcerative colitis.
  • http://insciences.org/article.php?article_id=7221
  • "New data demonstrate sustained efficacy of golimumab dosed every four weeks in patients with RA who were previously treated with anti-TNF agents," said Dr. Jonathan Kay, Professor of Medicine and Director of Clinical Research in the Rheumatology Divisio...
  • 1 2 3 4 5 6 7 8 9

    News

    A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis
    Mayo Clinic - Sunday, January 27, 2019
    Simponi Aria (golimumab) for Intravenous Infusion
    RXList - Tuesday, November 7, 2017
    Golimumab approved for psoriatic arthritis, ankylosing spondylitis
    Medwirenews - Thursday, November 2, 2017
    Simponi Aria Approved for Psoriatic Arthritis, Ankylosing Spondylitis
    P&T Community - Monday, October 23, 2017
    Trial results support intravenous golimumab for PsA
    Medwirenews - Monday, August 28, 2017
    IV Golimumab Succeeds in AS
    Medpage Today - Monday, June 19, 2017
    Remission Common in Early SpA With Golimumab
    Medpage Today - Friday, June 16, 2017
    Golimumab could be beneficial for children with JIA
    Medwirenews - Saturday, May 27, 2017
    Simponi (golimumab) Subcutaneous Injection
    RXList - Tuesday, February 14, 2017
    Sarcoidosis, neurotoxoplasmosis and golimumab therapy
    Oxford Journals - Friday, December 23, 2016
    IV Simponi Shows Promise in AS
    Medpage Today - Saturday, November 19, 2016
    Five-year safety data of golimumab remained consistent with 3-year data
    Healio - Wednesday, November 9, 2016
    Simponi Succeeds in Kids' Colitis (CME/CE)
    Medpage Today - Saturday, December 12, 2015
    Data show tolerability and effectiveness of SIMPONI in treating patients with active non-radiographic axial spondyloarthritis
    Medical News Today - Monday, November 23, 2015
    Simponi Tames Spine Inflammation
    Medpage Today - Tuesday, July 7, 2015
    SIMPONI receives European Commission approval for treatment of non-radiographic axial spondyloarthritis
    Medical News Today - Monday, June 29, 2015
    SIMPONI(R) Receives European Commission Approval for Treatment of Non-radiographic Axial Spondyloarthritis
    PR Newswire - Friday, June 26, 2015
    MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA
    News-Medical - Friday, June 26, 2015
    MORE NEWS

    Videos

    Golimumab (Simponi)
         
    A brief video describing the use of golimumab also known as Simponi for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

    How to Inject Simponi
         
    This video featuring Victoria Ruffing, RN of the Johns Hopkins Arthritis Center is designed to show patients how to inject Simponi.

    Inflammatory Markers Videos
         
  • underlying cause simponi side effects remicade nsaids inflammation humira enbrel depression complications big pharma

  • Golimumab (Simponi)
           
    A brief video describing the use of golimumab also known as Simponi for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

    How to Inject Simponi
           
    This video featuring Victoria Ruffing, RN of the Johns Hopkins Arthritis Center is designed to show patients how to inject Simponi.

    Simponi Videos
           
    Simponi Videos

    Mainstream Medicine Nixes Acupuncture - NaturalNews.tv
           
    It is amazing to me that drugs like NSAIDs and TNF-alpha drugs such as Humira, Enbrel, Remicade and Simponi would be recommended before considering acupuncture.

    Does Inflammation Cause Depression? - NaturalNews.tv
           
    Video Keywords: depression big pharma inflammation side effects nsaids underlying cause humira enbrel remicade simponi inflammatory markers complications

    Sham Acupuncture Videos
           
    tnf alpha inhibitor simponi safety remicade placebo nsaids nixes mainstream medicine humira enbrel acupuncture

    Tnf Alpha Inhibitor Videos
           
    simponi sham acupuncture safety remicade placebo nsaids nixes mainstream medicine humira enbrel acupuncture

    1 2 3 4 5 6 7 8 9

    Images

    simponi 02
    simponi 01
    simponi 35
    simponi 34
    simponi 33
    simponi 02
    drugs.com
    simponi 01
    drugs.com
    simponi 35
    drugs.com
    simponi 34
    drugs.com
    simponi 33
    drugs.com
    simponi 32
    simponi 31
    simponi 30
    simponi 29
    simponi 28
    simponi 32
    drugs.com
    simponi 31
    drugs.com
    simponi 30
    drugs.com
    simponi 29
    drugs.com
    simponi 28
    drugs.com
    simponi 27
    simponi 26
    Cover of Golimumab (Simponi) (Subcutaneous Injection)
    Golimumab can also be prescribed on the NHS to treat RA after the failure of conventional DMARDs
    simponi 9
    simponi 27
    drugs.com
    simponi 26
    drugs.com
    Cover of Golimumab (Simponi) (Subcutaneous Injection)
    ncbi.nlm.nih.gov
    Golimumab can also be prescribed on the NHS to treat RA after the failure of conventional DMARDs
    mims.co.uk
    simponi 9
    rxlist.com
    simponi 8
    simponi 7
    simponi 6
    simponi 18
    simponi 17
    simponi 8
    rxlist.com
    simponi 7
    rxlist.com
    simponi 6
    rxlist.com
    simponi 18
    rxlist.com
    simponi 17
    rxlist.com
    simponi 16
    simponi 15
    simponi 14
    simponi 13
    simponi 12
    simponi 16
    rxlist.com
    simponi 15
    rxlist.com
    simponi 14
    rxlist.com
    simponi 13
    rxlist.com
    simponi 12
    rxlist.com
    simponi 10
    golimumab
    FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis
    Simponi Q&A
    6th October 2010 - The National Institute for Health and Clinical Excellence (NICE) says it is unable to recommend golimumab (Simponi) for psoriatic arthritis on the NHS.
    simponi 10
    rxlist.com
    golimumab
    hopkinsarthritis.org
    FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis
    news-medical.net
    Simponi Q&A
    healthcentral.com
    6th October 2010 - The National Institute for Health and Clinical Excellence (NICE) says it is unable to recommend golimumab (Simponi) for psoriatic arthritis on the NHS.
    webmd.boots.com
    22nd October 2010 - The National Institute for Health and Clinical Excellence (NICE) says it needs more data before recommending the rheumatoid arthritis treatment golimumab.
    J&J seeks expanded use of Simponi
    NICE not impressed with Simponi for psoriatic arthritis
    22nd October 2010 - The National Institute for Health and Clinical Excellence (NICE) says it needs more data before recommending the rheumatoid arthritis treatment golimumab.
    webmd.boots.com
    J&J seeks expanded use of Simponi
    pharmatimes.com
    NICE not impressed with Simponi for psoriatic arthritis
    pharmatimes.com
    Cover of Golimumab (Simponi) (Subcutaneous Injection)
    Golimumab can also be prescribed on the NHS to treat RA after the failure of conventional DMARDs
    golimumab
    69x 75 patients and blood clots
    6th March 2012 - Thousands of patients in the UK are receiving artificial knee joints each year without sound evidence about their long-term safety and effectiveness, according to new research.
    Cover of Golimumab (Simponi) (Subcutaneous Injection)
    ncbi.nlm.nih.gov
    Golimumab can also be prescribed on the NHS to treat RA after the failure of conventional DMARDs
    mims.co.uk
    golimumab
    hopkinsarthritis.org
    69x 75 patients and blood clots
    webmd.boots.com
    6th March 2012 - Thousands of patients in the UK are receiving artificial knee joints each year without sound evidence about their long-term safety and effectiveness, according to new research.
    webmd.boots.com
    Crohns disease ulcerative colitis infliximab adalimumab golimumab NICE 20150225024150155
    Statins May Guard Against Rheumatoid Arthritis
    Crohns disease ulcerative colitis infliximab adalimumab golimumab NICE 20150225024150155
    mims.co.uk
    Statins May Guard Against Rheumatoid Arthritis
    healthday.com

    MORE IMAGES